祖拉诺龙在产后抑郁症中的真实安全性:FAERS分析
Lingbin Chen1, Weiping Pan2, Zhou Chen1
1School of Pharmacy, Fujian Medical University, Fuzhou, China.
Journal of affective disorders
|September 11, 2025
概括
这项研究分析了祖拉诺的不良药物反应,这是一种新的产后抑郁症治疗方法. 它发现,在营销后的数据中,关于精神和神经系统副作用的报道增加了,包括醉酒感.
科学领域:
- 药物监督和药物安全研究.
- 对新型疗法药物不良反应 (ADR) 的分析.
- 产后抑郁症 (PPD) 治疗安全性的监测.
背景情况:
- 祖拉诺是第一种被批准用于产后抑郁症的口服药物.
- 有限的营销后数据存在于祖拉诺龙的不良药物反应 (ADRs).
- 了解祖拉诺的安全概况对于患者的护理至关重要.
研究的目的:
- 为了识别zuranolone的潜在不成比例的药物不良反应 (ADR) 信号.
- 分析来自FDA不良事件报告系统 (FAERS) 的安全数据.
- 优先考虑zuranolone产品标签中未列出的安全信号.
主要方法:
- 从2023年第三季度到2025年第一季度利用了FDA不良事件报告系统 (FAERS) 数据库.
- 使用报告几率比率 (ROR) 和贝叶斯信心传播神经网络 (BCPNN) 方法进行不成比例分析.
- 对特定子组进行了临床优先级和敏感性分析.
主要成果:
- 确定了477个与祖拉诺使用相关的独特病例.
- 检测到显著的积极信号主要在神经系统和精神疾病中.
- 不在标签上显著的副作用包括醉酒,勃拉迪弗里尼亚,侵入性思想,高血压症和宿醉;报告了一起自杀死亡.
结论:
- 药监监测显示,在使用祖拉诺时,经常出现精神和神经方面的不良反应.
- FAERS数据表明,可能存在安全问题,需要进一步调查.
- 临床监测和研究对于确认报告的副作用的因果关系至关重要.
更多相关视频
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
811
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.5K
相关概念视频
Anxiolytic Drugs: Overview
1.1K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.1K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.4K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.4K
Antidepressant Drugs: MAOIs and Other Agents
831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
